The Trump administration has committed to spend $1.95 billion on
100 million doses of a potential COVID-19 vaccine being developed
by Germany’s BioNTech and US pharma giant Pfizer, which will be
distributed free of charge to American citizens.
BioNTech announced on Wednesday that the supply agreement signed
by the White House also includes the option for the US government
to purchase a further 500 million doses, subject to the vaccine
being granted regulatory approval.
Several governments have signed agreements with some of the 24
groups currently testing a coronavirus vaccine on humans, including
a promising candidate developed by Oxford university and
AstraZeneca, but most other purchasers have refused to reveal the
price paid per dose.
Source: FS – All – Science – News
US spends billion to secure COVID-19 vaccine